glp-1 for heart health The cardiovascular effects of receptor agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action GLP-1 for heart health?

Clinical trial data show that gastrointestinal adverse effectsincluding nausea, vomiting, diarrhea, and abdominal discomfortoccur in 20-50% of patients initiating GLP-1 therapy, with rates varying by specific agent and dose

Dehydration Semaglutide reduces appetite and, in some cases, thirst cues

Of the other phenotypes like convenient diner, fast-pacer, self-critic, all-or-nothing doer the medications don't tackle those really at all

When to Adjust Your Semaglutide Dose or Seek Personalized Guidance If nausea persists beyond 4 weeks or significantly interferes with daily function, a dose adjustment or temporary pause in escalation may be necessary